Selecta Biosciences, Inc.
USD0.88
-0.08 (-8.00%)
CEO
Carsten Brunn
IPO Date
2016-06-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.89
Prev. Close
$0.96
Day Low
$0.81
Day High
$0.94
52W Low
$0.79
52W High
$1.99
Market Cap
$0.14B
Volume
2.76M
| -1.3 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 49.9% | -72.0% | -0.02 | 1.33 | -0.5 |
| 31 Dec 2022 | FY | 34.7% | 31.9% | 37.7% | 21.3% | 0.40 | 5.91 | 4.6 |
| 31 Dec 2021 | FY | 19.2% | -30.2% | -114.1% | -16.1% | 1.57 | 2.00 | -14.5 |
| 31 Dec 2020 | FY | -228.4% | -420.5% | 387.6% | -42.2% | -1.96 | 1.86 | -4.4 |
| 31 Dec 2019 | FY | -540.2% | -801.8% | -637.6% | -53.8% | 2.30 | 2.77 | -2.0 |
| 31 Dec 2018 | FY | 100.0% | -7235.4% | 1205.9% | -146.9% | -3.95 | 1.20 | -0.9 |
| 31 Dec 2017 | FY | 100.0% | -31556.0% | -126.1% | -64.6% | 0.41 | 8.99 | -3.1 |
| 31 Dec 2016 | FY | 100.0% | -448.0% | -65.9% | -40.5% | 0.22 | 6.33 | -8.7 |
| -0.0 |
| 30 Sept 2025 | Q3 | 0.0% | -7942.9% | 100.2% | -9.6% | -0.35 | 10.67 | -0.1 |
| 30 Jun 2025 | Q2 | 0.0% | 5330.9% | -628.7% | 4.1% | -5.28 | 13.33 | 0.3 |
| 31 Mar 2025 | Q1 | 0.0% | -1610.0% | 81.3% | -4.3% | -0.65 | 12.34 | -1.5 |
| 31 Dec 2024 | Q4 | 88.2% | -147.7% | 459.9% | -7.2% | -2.06 | 9.43 | -0.8 |
| 30 Sept 2024 | Q3 | 0.0% | -6248.8% | -3215.8% | -5.3% | 19.48 | 10.70 | -1.1 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 0.0% | 0.0% | -0.02 | 1.33 | 0.0 |
| 30 Sept 2023 | Q3 | 100.0% | -137.4% | -14.9% | -8.5% | 0.17 | 4.51 | -4.6 |
| 30 Jun 2023 | Q2 | -238.8% | -216.9% | -17.4% | -8.2% | 0.53 | 4.18 | -3.8 |